HRT Financial’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

HRT Financial’s Portfolio BIOR Stock Details BIOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,380	Closed	-$16K	–	3500
2024 Q3	$16K	Buy	+3,380	New	+$21.9K	﹤0.01%	2208
2023 Q1	–	Sell	-294	Closed	-$9K	–	3615
2022 Q4	$9K	Buy	294 +221	+303%	+$16.1K	﹤0.01%	2235
2022 Q3	$8K	Sell	73 -27	-27%	-$4.86K	﹤0.01%	2563
2022 Q2	$17K	Sell	100 -213	-68%	-$44.9K	﹤0.01%	2630
2022 Q1	$90K	Buy	+313	New	+$119K	﹤0.01%	2681
2021 Q3	–	Sell	-156	Closed	-$139K	–	3937
2021 Q2	$139K	Sell	156 -145	-48%	-$111K	﹤0.01%	2514
2021 Q1	$357K	Buy	+301	New	+$415K	﹤0.01%	2011
2020 Q4	–	Sell	-56	Closed	-$126K	–	2683
2020 Q3	$126K	Buy	+56	New	+$127K	﹤0.01%	1478

HRT Financial's BIOR Position: Q4 2024 in Review

HRT Financial sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q4 2024, closing a stake of 3,380 shares — an estimated $16K sold.

HRT Financial first reported a position in BIOR in Q3 2020 and held it in 8 quarters. The position peaked at $357K in Q1 2021. 0 funds tracked by Wall St. Rank hold BIOR as of Q4 2024.

HRT Financial reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
HRT Financial sold 3,380 Biora Therapeutics, Inc. Common Stock shares in Q4 2024, an estimated $16K.
HRT Financial first reported a position in Biora Therapeutics, Inc. Common Stock in Q3 2020 and held it in 8 quarters.
HRT Financial's Biora Therapeutics, Inc. Common Stock position peaked at $357K in Q1 2021.
0 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q4 2024.

Based on HRT Financial's 13F filing for Q4 2024, filed 14 Feb 2025.